Next-Generation CAR-T Therapies: Optimizing Opportunities and Operationalizing Patient-Centric Oncology Clinical Trials

Chimeric antigen receptor (CAR)-T cell therapies have become an important treatment modality for cancer but there remains a significant opportunity to enhance CAR-T therapies and leverage these therapeutics to address unmet clinical needs.

As these therapies evolve, their application is expanding beyond hematologic malignancies and advancements in science and technology are improving their efficacy, safety and durability of response. Next-generation CAR-T therapies have the potential to further transform the cancer treatment landscape by positively impacting outcomes, reducing toxicities and logistical complexity and enhancing patient accessibility and convenience.

In this webinar, the expert speakers will explore the latest innovations in CAR-T therapy and discuss key operational considerations aimed at improving the efficiency of clinical trials and enriching the experience of study participation for oncology patients.

Register for this webinar today to gain insights into how next-generation CAR-T therapies are transforming cancer care, focusing on enhancing patient outcomes and streamlining oncology clinical trials.

Speakers

Ashley Herrick, PhD, VP, Oncology Strategy, Premier Research

Ashley Herrick is responsible for providing strategic planning, coordination, knowledge and expertise for oncology projects. She has more than 14 years of experience in clinical trial oversight and drug development with a focus on oncology research. She has experience across all phases of clinical trial development with a keen interest and extensive knowledge of early phase and first-in-human studies.

Ashley has previous experience as a Director of Operational Strategy Management for a mid-sized CRO where she oversaw strategic study planning and supported their oncology site network, responsible for oversight of a biomarker-driven patient matching group. Over her career, Ashley has also served as Project Director, Project Manager and CRA and has devoted her entire career to oncology research.

Read more...

Prior to joining the CRO industry, she worked as a Program Manager for the largest phase 1 clinical trial unit in the country at MD Anderson Cancer Center, where she was responsible for oversight of more than 50 industry-sponsored and investigator-led Phase I clinical trials. More recently, Ashley has strategic experience in building our CAR-T Oncology experience within Premier Research. She has expert knowledge on many of the next-generation CAR-T therapies emerging and has experience in overseeing studies with switchable CAR-T therapies, CAR-T combination therapies and in vivo CAR-T therapies.

Ashley holds a PhD in Molecular and Cellular Biology with a focus on acute myeloid leukemia from Baylor College of Medicine. She is also CCRP-certified and is a member of the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). She is an active volunteer with the Leukemia and Lymphoma Society (LLS).

Read Less...

Message Presenter

Meera Belur, Executive Director, Program Strategy, Oncology, Premier Research

Meera Belur, Executive Director, Program Strategy, Oncology, joined Premier Research in 2024 and is an integral member of the oncology leadership team responsible for providing strategic planning, coordination, knowledge and expertise for oncology and hematology projects.

She brings more than 20 years of industry experience (academia, small biotechs, large pharma and CROs). Prior to joining Premier Research, Meera served as the Portfolio Group Head for a large pharma company overseeing radioligand, CAR-T and gene therapy assets within the Oncology business unit. Meera has a diverse background in global clinical operations, drug development and project management where she has a proven track record of providing strategic leadership and successfully managing multiple aspects of numerous global Phase I-IV clinical trials across various therapeutic areas with a reputation for building and maintaining top-tier project management teams.

Message Presenter